These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30909753)

  • 21. Hydration induced material transfer in membranes of osmotic pump tablets measured by synchrotron radiation based FTIR.
    Wu L; Yin X; Guo Z; Tong Y; Feng J; York P; Xiao T; Chen M; Gu J; Zhang J
    Eur J Pharm Sci; 2016 Mar; 84():132-8. PubMed ID: 26802550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel time-controlled release system based on drug-resin complexes and elementary osmotic pump.
    Wang C; Chen F; Heng PW; Li JZ; Li X; Ye GH; Nie SF; Pan WS
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):457-63. PubMed ID: 18379090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo.
    Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G
    Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
    Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
    Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo.
    Wang X; Nie SF; Li W; Luan L; Pan W
    Drug Dev Ind Pharm; 2007 Sep; 33(9):1024-9. PubMed ID: 17891589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
    Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
    Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.
    Lu EX; Jiang ZQ; Zhang QZ; Jiang XG
    J Control Release; 2003 Oct; 92(3):375-82. PubMed ID: 14568418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study and Evaluation on Preparation of Monolithic Osmotic Pump Tablet of Resveratrol].
    Wu XC; Hao HJ; Song XY; Zhang YZ; Liu YX; Zhang HQ
    Zhong Yao Cai; 2015 Aug; 38(8):1732-5. PubMed ID: 26983250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zero-Order Controlled Delivery of Gliclazide from Polyethylene Oxides Matrix Tables: In vitro and In vivo Evaluation.
    Wang L; Yang X; Di Y; Chen K; Wen H; Pan W
    Curr Drug Deliv; 2017; 14(1):136-144. PubMed ID: 27000027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclodextrin complex osmotic tablet for glipizide delivery.
    Gan Y; Pan W; Wei M; Zhang R
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.
    Lin W; Li Y; Shi Q; Liao X; Zeng Y; Tian W; Xie X; Liu H
    PLoS One; 2022; 17(2):e0264457. PubMed ID: 35213658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
    Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
    J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.